MARKET

GANX

GANX

Gain Therapeutics, Inc.
NASDAQ
1.080
-0.010
-0.92%
After Hours: 1.080 0 0.00% 19:30 11/10 EST
OPEN
1.100
PREV CLOSE
1.090
HIGH
1.180
LOW
1.050
VOLUME
411.69K
TURNOVER
--
52 WEEK HIGH
4.340
52 WEEK LOW
0.9402
MARKET CAP
47.14M
P/E (TTM)
-2.1061
1D
5D
1M
3M
1Y
5Y
1D
Gain Therapeutics Q3 Loss Narrows
NASDAQ · 7h ago
Gain Therapeutics reports Q3 EPS (7c), consensus (13c)
TipRanks · 9h ago
Gain Therapeutics GAAP EPS of -$0.07 beats by $0.05
Seeking Alpha · 11h ago
*Gain Therapeutics 3Q Loss/Shr 7c >GANX
Dow Jones · 13h ago
*Gain Therapeutics 3Q Loss $3.16M >GANX
Dow Jones · 13h ago
Press Release: Gain Therapeutics Reports -2-
Dow Jones · 14h ago
Weekly Report: what happened at GANX last week (1102-1106)?
Weekly Report · 1d ago
Weekly Report: what happened at GANX last week (1026-1030)?
Weekly Report · 11/02 09:30
More
About GANX
Gain Therapeutics, Inc. is a biotechnology company. The Company is focused on developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company’s drug discovery platform, Magellan discovers novel allosteric binding sites on proteins implicated in a disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Its lead product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson’s disease, including restoration of glucocerebrosidase or GCase, function in the lysosome, reduction of toxic lipid substrates and toxic forms of alpha-synuclein, improved survival of dopaminergic neurons, and enhance in dopamine levels.

Webull offers Gain Therapeutics Inc stock information, including NASDAQ: GANX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GANX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GANX stock methods without spending real money on the virtual paper trading platform.